β-Glucans inhibit intracellular growth of Mycobacterium bovis BCG but not virulent Mycobacterium tuberculosis in human macrophages

Microbial Pathogenesis

Volumn 51, Issue 4, 2011, Pages 233-242

  Betz, Bret E ^a   Azad, Abul K ^a   Morris, Jessica D ^a   Rajaram, Murugesan V S ^a   Schlesinger, Larry S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

glucan; Dectin 1; Macrophages; Mycobacterium bovis BCG; Mycobacterium tuberculosis; Oxidative burst

Indexed keywords

ANTIBIOTIC AGENT; BETA GLUCAN; BETAFECTIN; DECTIN 1; UNCLASSIFIED DRUG; WHOLE GLUCAN PARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL VIRULENCE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; GROWTH INHIBITION; HOST RESISTANCE; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MACROPHAGE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; SACCHAROMYCES CEREVISIAE; SPECIES DIFFERENCE;

BETA-GLUCANS; CYTOKINES; HUMANS; IMMUNOLOGIC FACTORS; MACROPHAGES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RESPIRATORY BURST; SACCHAROMYCES CEREVISIAE;

MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; SACCHAROMYCES CEREVISIAE;

EID: 79960926282     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.06.006     Document Type: Article

References (37)

1. LeBlanc B.W., Albina J.E., Reichner J.S. The effect of PGG-beta-glucan on neutrophil chemotaxis in vivo. J Leukoc Biol 2006, 79(4):667-675.
2. Goodridge H.S., Wolf A.J., Underhill D.M. Beta-glucan recognition by the innate immune system. Immunol Rev 2009, 230(1):38-50.
3. Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., et al. Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice. Microbiol Immunol 2006, 50(9):687-700.
4. Li J., Li D.F., Xing J.J., Cheng Z.B., Lai C.H. Effects of beta-glucan extracted from Saccharomyces cerevisiae on growth performance, and immunological and somatotropic responses of pigs challenged with Escherichia coli lipopolysaccharide. J Anim Sci 2006, 84(9):2374-2381.
5. Hetland G., Ohno N., Aaberge I.S., Lovik M. Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice. FEMS Immunol Med Microbiol 2000, 27(2):111-116.
6. Liang J., Melican D., Cafro L., Palace G., Fisette L., Armstrong R., et al. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol 1998, 20(11):595-614.
7. Hetland G., Lovik M., Wiker H.G. Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice. Scand J Immunol 1998, 47(6):548-553.
8. Hetland G., Sandven P. beta-1,3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures. FEMS Immunol Med Microbiol 2002, 33(1):41-45.
9. Xia Y., Vetvicka V., Yan J., Hanikyrova M., Mayadas T., Ross G.D. The β-glucan-ginding lectin site of mouse cr3 (cd11b/cd18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to ic3b-opsonized target cells1. J.Immunol 1999, 162:2281-2290.
10. Tsoni S.V., Brown G.D. beta-Glucans and dectin-1. Ann N Y Acad Sci 2008, 1143:45-60.
11. Taylor P.R., Brown G.D., Reid D.M., Willment J.A., Martinez-Pomares L., Gordon S., et al. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 2002, 169(7):3876-3882.
12. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003, 197(9):1119-1124.
13. Reid D.M., Gow N.A., Brown D.G. Pattern recognition: recent insights from Dectin-1. Curr Opin Microbiol 2009, 21:30-37.
14. Kankkunen P., Teirila L., Rintahaka J., Alenius H., Wolff H., Matikainen S. (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J Immunol 2010, 184(11):6335-6342.
15. Flannagan R.S., Cosio G., Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 2009, 7(5):355-366.
16. Ferguson J.S., Martin J.L., Azad A.K., McCarthy T.R., Kang P.B., Voelker D.R., et al. Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun 2006, 74(12):7005-7009.
17. Fenton M.J., Riley L.W., Schlesinger L.S. Receptor-Mediated recognition of Mycobacterium tuberculosis by host cells. Tuberculosis and the Tubercle Bacillus 2005, 405-426. ASM Press, New York. S.T. Cole, K.D. Eisenach, D.N. McMurray, W.R. Jacobs (Eds.).
18. Yadav M., Schorey J.S. The {beta}-glucan receptor Dectin-1 fucntions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 2006, 108:3168-3175.
19. Schlesinger L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993, 150:2920-2930.
20. Kang B.K., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A.A., Tibesar E., et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 2005, 202(7):987-999.
21. Hempel S.L., Buettner G.R., O'Malley Y.Q., Wessels D.A., Flaherty D.M. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 1999, 27(1-2):146-159.
22. Harnack U., Eckert K., Fichtner I., Pecher G. Oral administration of a soluble 1-3, 1-6 beta-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice. Int Immunopharmacol 2009, 9(11):1298-1303.
23. Kimura Y., Sumiyoshi M., Suzuki T., Sakanaka M. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast. Anticancer Res 2006, 26(6B):4131-4141.
24. Yan J., Allendorf D.J., Brandley B. Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opin Biol Ther 2005, 5(5):691-702.
25. Stuyven E., Cox E., Vancaeneghem S., Arnouts S., Deprez P., Goddeeris B.M. Effect of beta-glucans on an ETEC infection in piglets. Vet Immunol Immunopathol 2009, 128(1-3):60-66.
26. Shah V.B., Huang Y., Keshwara R., Ozment-Skelton T., Williams D.L., Keshvara L. Beta-glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner. J Immunol 2008, 180(5):2777-2785.
27. Li B., Cramer D., Wagner S., Hansen R., King C., Kakar S., et al. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways. Clin Immunol 2007, 124(2):170-181.
28. Michalek M., Melican D., Brunke-Reese D., Langevin M., Lemerise K., Galbraith W., et al. Activation of rat macrophages by Betafectin PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J Leukoc Biol 1998, 64(3):337-344.
29. Qi C., Cai Y., Gunn L., Ding C., Li B., Kloecker G., et al. Differential pathways regulating innate and adaptive anti-tumor immune responses by particulate and soluble yeast-derived {beta}-glucans. Blood 2011.
30. Goodridge H.S., Reyes C.N., Becker C.A., Katsumoto T.R., Ma J., Wolf A.J., et al. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature 2011, 472(7344):471-475.
31. Ni L., Gayet I., Zurawski S., Duluc D., Flamar A.L., Li X.H., et al. Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses. J Immunol 2010, 185(6):3504-3513.
32. Zenaro E., Donini M., Dusi S. Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, Mannose Receptor, and DC-SIGN. J Leukoc Biol 2009, 86(6):1393-1401.
33. Schorey J.S., Lawrence C. The pattern recognition receptor Dectin-1: from fungi to mycobacteria. Curr Drug Targets 2008, 9(2):123-129.
34. Crowther J.E., Kutala V.K., Kuppusamy P., Ferguson J.S., Beharka A.A., Zweier J.L., et al. Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol 2004, 172(11):6866-6874.
35. Beharka A.A., Gaynor C.D., Kang B.K., Voelker D.R., McCormack F.X., Schlesinger L.S. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002, 169:3565-3573.
36. Olakanmi O., Britigan B.E., Schlesinger L.S. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect Immun 2000, 68(10):5619-5627.
37. Schlesinger L.S., Bellinger-Kawahara C.G., Payne N.R., Horwitz M.A. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990, 144:2771-2780.